BriaCell Therapeutics - Warrants (24/02/2025) Net Tangible Assets

BriaCell Therapeutics - Warrants (24/02/2025) (BCTXW) currently reports a net tangible assets of $23M as of April 2026. That compares with $12M in the prior-year period — up 96.0% year over year. Use the charts on this page to explore BriaCell Therapeutics - Warrants (24/02/2025)'s net tangible assets history and peer comparisons.

BriaCell Therapeutics - Warrants (24/02/2025)'s net tangible assets increased from $12M to $23M — a 96.0% year-over-year increase (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BriaCell Therapeutics - Warrants (24/02/2025) reported $23M in net tangible assets as of April 2026. That compares with $12M in the prior-year period — up 96.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BriaCell Therapeutics - Warrants (24/02/2025), and consider following BCTXW for alerts when major investors trade the stock.

BriaCell Therapeutics - Warrants (24/02/2025) is classified in the Healthcare sector. On net tangible assets, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BCTXW with unrelated industries.